Schedule 13G ownership disclosure
ADAGIO MED HLDGS INC
Common Stock, par value $0.0001 per share · CUSIP: 00534B100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 15,321,655 · Class: 57.5%
- Joseph Edelman
Shares: 15,321,655 · Class: 57.5%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 15,120,753 · Class: 56.8%
- C2 Life Sciences LLC
Shares: 200,902 · Class: 0.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-054521
- Form type
- SCHEDULE 13G/A
- Filer
- Adagio Medical Holdings, Inc.
- CIK
- CIK 2006986
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership